Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AYTU	AYTU BIOPHARMA INC	$13.51M	5.30%	1.40%	18.88%	993.50%	2.56	1.03	68.60%	2.40%	14.59%
ZVRA	ZEVRA THERAPEUTICS INC	$499.60M	4.00%	1.30%	13.14%	23.30%	1.19	7.85	72.00%	4.30%	48.18%
QGEN	QIAGEN NV	$10.66B	10.70%	6.40%	11.21%	17.50%	0.66	1.61	63.00%	18.30%	25.79%
BHC	BAUSCH HEALTH COMPANIES INC	$2.78B	-8.90%	0.40%	8.12%	7.10%	-35.50	1.31	70.70%	1.00%	18.35%
BDX	BECTON DICKINSON & CO	$55.89B	6.20%	2.90%	5.35%	8.70%	1.16	1.10	44.90%	7.40%	11.69%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.36B	6.20%	4.70%	7.50%	21.60%	0.30	2.58	88.50%	9.70%	12.35%
FENC	FENNEC PHARMACEUTICALS INC	$235.59M	N/A	-27.10%	-27.47%	-28.60%	-8.89	5.13	90.30%	-46.70%	-33.79%
VREX	VAREX IMAGING CORP	$447.37M	-7.60%	-3.30%	4.45%	4.80%	1.44	4.05	33.70%	-5.10%	6.39%
ATRC	ATRICURE INC	$1.76B	-7.90%	-6.00%	-5.42%	-14.20%	0.31	3.94	74.70%	-7.30%	-5.85%
WST	WEST PHARMACEUTICAL SERVICES INC	$17.70B	17.70%	13.10%	18.27%	21.20%	0.35	2.78	35.30%	16.50%	20.66%
KRMD	KORU MEDICAL SYSTEMS INC	$190.49M	-26.80%	-16.80%	-23.09%	-31.40%	0.54	2.91	63.20%	-12.30%	-12.20%
GMED	GLOBUS MEDICAL INC	$8.11B	8.60%	7.10%	8.18%	19.10%	0.16	4.07	62.80%	13.60%	14.13%
COR	CENCORA INC	$57.17B	196.30%	2.70%	13.97%	53.40%	36.23	0.91	3.50%	0.60%	0.88%
TMDX	TRANSMEDICS GROUP INC	$4.42B	28.00%	8.60%	10.58%	9.50%	1.80	9.86	59.80%	13.50%	16.60%
WGS	GENEDX HOLDINGS CORP	$3.53B	0.60%	0.30%	1.16%	1.90%	0.67	2.87	67.20%	0.40%	1.25%
TXG	10X GENOMICS INC	$1.63B	-21.90%	-17.00%	-19.28%	-30.90%	0.28	5.37	68.40%	-25.10%	-24.56%
AHCO	ADAPTHEALTH CORP	$1.28B	5.20%	1.80%	7.02%	8.50%	1.74	1.06	22.00%	2.50%	8.08%
DOMH	DOMINARI HOLDINGS INC	$95.28M	-36.60%	-30.20%	-20.49%	-35.90%	0.24	3.65	100.00%	-36.00%	-36.01%
EXAS	EXACT SCIENCES CORP	$8.52B	-38.40%	-16.60%	-18.49%	-24.70%	1.35	2.89	68.20%	-34.20%	-33.18%
SNYR	SYNERGY CHC CORP	$32.00M	-11.60%	17.50%	85.30%	22.80%	-2.00	1.91	68.60%	7.20%	19.27%
ISRG	INTUITIVE SURGICAL INC	$171.02B	15.60%	13.70%	16.04%	21.80%	0.12	5.17	66.60%	28.50%	32.39%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$1.92B	-62.60%	-25.20%	-29.82%	-25.00%	1.54	3.20	89.10%	-35.40%	-28.13%
AVNS	AVANOS MEDICAL INC	$508.57M	-50.40%	-37.40%	-51.86%	-96.70%	0.34	2.65	53.80%	-66.90%	-67.73%
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$33.63B	25.10%	6.60%	12.41%	19.40%	2.63	1.16	41.60%	11.20%	16.01%
CVS	CVS HEALTH CORP	$84.64B	5.90%	1.80%	5.84%	7.90%	2.34	0.80	13.80%	1.20%	2.48%
SNY	SANOFI	$123.89B	12.80%	7.20%	11.91%	27.80%	0.78	1.27	71.60%	21.20%	26.49%
GDRX	GOODRX HOLDINGS INC	$1.23B	5.10%	2.60%	8.49%	12.70%	1.05	4.21	93.70%	4.30%	12.61%
HQY	HEALTHEQUITY INC	$7.56B	5.70%	3.50%	6.59%	16.90%	0.61	4.06	65.50%	9.80%	17.49%
PHR	PHREESIA INC	$1.67B	-16.20%	-11.20%	-13.65%	-79.80%	0.42	1.95	68.00%	-9.80%	-9.10%
VCYT	VERACYTE INC	$2.35B	2.80%	2.60%	2.83%	23.70%	0.10	5.10	68.00%	7.10%	7.57%
FOLD	AMICUS THERAPEUTICS INC	$2.19B	-19.80%	-4.80%	3.89%	3.80%	2.99	3.21	90.40%	-6.70%	4.41%
EXEL	EXELIXIS INC	$10.36B	27.70%	21.10%	33.12%	32.40%	0.32	3.51	96.60%	27.00%	34.78%
MCK	MCKESSON CORP	$83.81B	-124.80%	4.20%	25.78%	60.50%	-42.15	0.88	3.60%	0.80%	1.16%
ATEC	ALPHATEC HOLDINGS INC	$2.30B	N/A	-21.40%	-20.72%	-14.60%	32.25	2.88	68.80%	-24.30%	-19.32%
ANGO	ANGIODYNAMICS INC	$354.73M	-18.10%	-11.80%	-17.17%	-42.10%	0.53	2.21	53.90%	-11.60%	-11.97%
PNTG	PENNANT GROUP INC	$853.68M	9.90%	3.80%	6.44%	6.20%	1.33	1.21	13.80%	3.40%	5.21%
CCLD	CARECLOUD INC	$108.34M	0.00%	0.00%	20.01%	82.40%	0.34	1.91	46.00%	0.00%	10.56%
JNJ	JOHNSON & JOHNSON	$420.78B	30.40%	12.20%	20.25%	43.20%	1.46	1.01	67.90%	25.00%	31.10%
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.28B	-9.80%	-6.00%	-5.55%	-4.40%	0.78	11.93	82.30%	-20.40%	-16.54%
TVTX	TRAVERE THERAPEUTICS INC	$1.62B	-717.90%	-30.70%	-43.16%	-26.40%	15.96	2.00	96.90%	-50.60%	-47.28%
DHR	DANAHER CORP	$150.53B	6.70%	4.30%	5.84%	16.50%	0.56	1.62	59.70%	14.20%	18.19%
ACAD	ACADIA PHARMACEUTICALS INC	$4.11B	35.30%	21.70%	31.92%	64.00%	0.48	2.88	92.00%	23.00%	26.58%
A	AGILENT TECHNOLOGIES INC	$33.77B	19.50%	9.90%	14.61%	22.30%	0.98	2.09	53.30%	17.60%	22.36%
ASND	ASCENDIS PHARMA A	$11.65B	N/A	-33.40%	-107.48%	-42.00%	-6.59	1.04	85.30%	-92.70%	-51.29%
LFST	LIFESTANCE HEALTH GROUP INC	$2.17B	-2.50%	-1.70%	-0.77%	-1.90%	0.44	1.47	32.50%	-2.80%	-1.14%
ABUS	ARBUTUS BIOPHARMA CORP	$646.02M	-59.20%	-44.10%	-55.10%	-68.90%	0.25	20.53	100.00%	-351.90%	-351.17%
PDEX	PRO DEX INC	$132.76M	29.10%	16.20%	28.59%	23.30%	0.82	2.73	31.40%	14.60%	20.49%
DCTH	DELCATH SYSTEMS INC	$366.25M	3.40%	2.90%	1.18%	2.70%	0.11	10.88	85.90%	3.20%	1.79%
PRGO	PERRIGO CO PLC	$3.17B	-1.80%	-0.80%	2.92%	4.20%	1.26	2.32	35.70%	-1.90%	6.05%
XOMA	XOMA ROYALTY CORP	$381.85M	-15.30%	-5.60%	-2.21%	-2.40%	1.81	4.88	100.00%	-27.60%	-9.92%
BIO	BIO-RAD LABORATORIES INC	$7.77B	4.60%	3.20%	5.16%	5.20%	0.43	5.12	52.80%	12.50%	19.54%
PLX	PROTALIX BIOTHERAPEUTICS INC	$121.19M	14.70%	8.70%	16.88%	29.10%	0.57	2.72	57.50%	10.10%	14.82%
AORT	ARTIVION INC	$1.83B	-7.30%	-2.70%	1.56%	1.90%	1.69	5.53	63.90%	-5.50%	2.95%
DVA	DAVITA INC	$9.61B	-2,595.20%	4.80%	11.54%	9.20%	-43.12	1.39	32.50%	6.40%	12.77%
HCM	HUTCHMED (CHINA) LTD	$2.77B	5.10%	3.00%	5.32%	6.30%	0.66	2.83	44.60%	6.00%	7.58%
WRBY	WARBY PARKER INC	$3.26B	-4.20%	-2.20%	-4.02%	-4.60%	0.93	2.70	55.30%	-1.80%	-2.83%
DGX	QUEST DIAGNOSTICS INC	$19.95B	13.70%	5.90%	10.66%	15.20%	1.20	1.09	33.00%	9.00%	14.13%
HOLX	HOLOGIC INC	$15.14B	11.50%	6.30%	10.15%	18.50%	0.82	3.56	51.80%	13.80%	19.71%
FHTX	FOGHORN THERAPEUTICS INC	$290.85M	N/A	-28.00%	-50.79%	-44.10%	-3.95	2.62	100.00%	-311.90%	-311.90%
ETON	ETON PHARMACEUTICALS INC	$447.85M	-23.40%	-8.00%	-3.86%	-14.50%	2.44	1.97	59.40%	-9.30%	-4.59%
IONS	IONIS PHARMACEUTICALS INC	$6.83B	-45.50%	-9.00%	-8.77%	-5.00%	3.73	2.87	98.90%	-28.40%	-19.40%
ZTS	ZOETIS INC	$67.83B	53.20%	18.30%	31.70%	28.10%	1.91	1.76	71.50%	27.80%	37.54%
IMAB	I-MAB	$421.27M	-3.50%	-3.30%	-3.77%	-5.70%	0.05	22.35	N/A	N/A	N/A
CNMD	CONMED CORP	$1.63B	11.40%	4.80%	8.45%	11.60%	1.32	2.23	56.10%	8.30%	12.96%
ALHC	ALIGNMENT HEALTHCARE INC	$2.93B	-44.00%	-6.00%	-5.82%	-10.50%	6.10	1.66	12.10%	-1.50%	-0.82%
AUNA	AUNA SA	$467.49M	N/A	N/A	N/A	N/A	N/A	N/A	38.90%	3.70%	17.38%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.10B	26.30%	17.70%	25.99%	53.80%	0.43	3.84	78.30%	23.40%	31.22%
FTRE	FORTREA HOLDINGS INC	$711.00M	-95.00%	-31.10%	-49.46%	-65.70%	3.81	1.02	19.70%	-37.60%	-34.25%
ELV	ELEVANCE HEALTH INC	$66.52B	12.50%	4.50%	10.76%	14.30%	1.79	1.45	15.50%	2.80%	4.44%
ARGX	ARGENX SE	$39.82B	24.70%	21.40%	10.88%	20.20%	0.18	5.60	-19,733.10%	78,552.00%	40,946.87%
HSTM	HEALTHSTREAM INC	$768.89M	5.70%	4.00%	6.52%	42.30%	0.43	1.25	65.60%	6.90%	8.49%
ESPR	ESPERION THERAPEUTICS INC	$417.36M	N/A	-31.30%	-67.51%	-5.90%	-1.80	1.15	61.60%	-38.80%	-12.16%
LXRX	LEXICON PHARMACEUTICALS INC	$428.81M	-83.60%	-42.20%	-56.64%	-49.10%	0.74	4.17	99.20%	-206.40%	-184.91%
SIBN	SI-BONE INC	$660.06M	-14.20%	-10.40%	-10.07%	-10.10%	0.36	8.38	79.40%	-12.80%	-11.21%
RMD	RESMED INC	$41.75B	25.20%	18.20%	23.92%	47.80%	0.36	3.41	58.80%	26.20%	31.56%
SMTI	SANARA MEDTECH INC	$270.63M	-26.30%	-10.70%	-5.50%	-8.50%	1.79	2.26	91.80%	-10.20%	-4.74%
NUTX	NUTEX HEALTH INC	$618.51M	57.60%	11.80%	20.74%	17.60%	2.47	2.27	48.80%	10.80%	19.45%
HNGE	HINGE HEALTH INC	$4.49B	N/A	N/A	N/A	N/A	1.84	1.91	N/A	N/A	N/A
USPH	U S PHYSICAL THERAPY INC	$1.31B	6.80%	3.00%	5.39%	13.50%	0.85	1.17	18.10%	4.80%	8.14%
PEN	PENUMBRA INC	$9.87B	12.40%	9.40%	11.42%	15.60%	0.29	6.75	66.50%	11.50%	13.54%
REGN	REGENERON PHARMACEUTICALS INC	$59.99B	15.10%	11.80%	14.21%	14.80%	0.28	4.60	85.60%	31.40%	34.55%
HSIC	HENRY SCHEIN INC	$8.24B	11.40%	3.70%	8.36%	11.80%	1.74	1.41	31.30%	3.00%	5.17%
TGTX	TG THERAPEUTICS INC	$4.41B	26.10%	9.60%	18.37%	16.60%	1.54	3.86	87.00%	13.30%	21.47%
CI	CIGNA GROUP	$77.50B	12.30%	3.30%	8.35%	16.40%	2.77	0.79	9.90%	1.90%	3.02%
HUM	HUMANA INC	$33.84B	9.00%	3.20%	8.30%	8.80%	1.76	1.95	15.00%	1.30%	2.23%
ZBH	ZIMMER BIOMET HOLDINGS INC	$20.23B	6.60%	3.70%	6.11%	10.70%	0.83	1.87	71.10%	10.50%	15.74%
DOCS	DOXIMITY INC	$11.93B	22.40%	19.30%	23.79%	34.00%	0.17	6.97	90.20%	39.10%	46.21%
LMAT	LEMAITRE VASCULAR INC	$2.17B	13.70%	9.10%	11.65%	12.60%	0.59	13.96	69.10%	20.10%	27.14%
JAZZ	JAZZ PHARMACEUTICALS PLC	$7.08B	-10.00%	-3.50%	-3.40%	-4.00%	1.95	1.62	88.70%	-9.90%	-7.37%
MDGL	MADRIGAL PHARMACEUTICALS INC	$8.28B	-38.40%	-27.30%	-32.75%	-34.00%	0.46	5.11	96.30%	-54.70%	-52.01%
COO	COOPER COMPANIES INC	$14.65B	5.10%	3.40%	6.45%	9.00%	0.50	2.10	67.20%	10.40%	18.45%
MDT	MEDTRONIC PLC	$117.85B	9.60%	5.20%	8.03%	12.30%	0.90	1.85	65.30%	13.90%	18.87%
PFE	PFIZER INC	$142.76B	12.00%	5.10%	6.25%	9.50%	1.32	1.16	72.10%	16.80%	16.48%
SLNO	SOLENO THERAPEUTICS INC	$4.11B	-73.70%	-56.70%	-57.20%	-67.90%	0.38	15.13	97.90%	-554.50%	-545.40%
EBS	EMERGENT BIOSOLUTIONS INC	$478.73M	-27.30%	-9.10%	-0.07%	-0.10%	1.58	6.32	35.20%	-13.60%	-0.09%
AZTA	AZENTA INC	$1.40B	-6.50%	-5.40%	-5.63%	-13.30%	0.21	2.76	44.90%	-18.40%	-16.50%
AMN	AMN HEALTHCARE SERVICES INC	$714.77M	-20.70%	-6.50%	-7.18%	-8.10%	2.35	1.08	30.10%	-5.80%	-4.56%
ALKS	ALKERMES PLC	$4.67B	23.70%	16.30%	24.13%	31.70%	0.39	3.23	85.10%	23.10%	28.00%
ICUI	ICU MEDICAL INC	$2.76B	-1.80%	-0.90%	2.94%	4.00%	0.94	2.44	35.80%	-1.60%	4.49%
MEDP	MEDPACE HOLDINGS INC	$12.89B	67.70%	21.90%	136.65%	-206.60%	8.12	0.43	31.60%	18.70%	21.51%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-116.18x	4.42x	-121.17%	-6.90%	-1.45%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.84x	-3.66%	+7.34%	+14.22%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	34.55x	5.87x	+58.71%	+10.34%	+17.79%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-10.62x	2.24x	+12.23%	+4.91%	+10.43%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.12x	1.76x	+15.36%	+4.82%	+11.26%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	80.97x	4.02x	+7.39%	+4.83%	+9.55%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.89x	4.70x	-194.08%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.59x	3.98x	+13.01%	+8.47%	+10.00%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.65x	289.07x	-6.50%	+3.03%	+18.71%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	32.98x	3.50x	+10.58%	+8.31%	+11.13%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 75.79% over the past year, overperforming other healthcare stocks by 124 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.97% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 58.19% over the past year, overperforming other healthcare stocks by 106 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 2%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Leap Therapeutics was the among the top losers in the healthcare sector, dropping -28.02% yesterday.

Leap Therapeutics shares are trading lower after the company reported a Q2 EPS miss.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -5.97% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.98% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 95.95% in the past year. It has overperformed other stocks in the healthcare sector by 144 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.22x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.